Update on retinoblastoma

DH Abramson, AC Schefler - Retina, 2004 - journals.lww.com
After completion of this article, the reader will be able to 1) state the therapeutic interventions
that are currently used to treat intraocular retinoblastoma, and to outline the mechanism of …

Retinoblastoma: review of current management

M Chintagumpala, P Chevez-Barrios, EA Paysse… - The …, 2007 - academic.oup.com
Learning Objectives After completing this course, the reader will be able to: Discuss the
need for a multidisciplinary approach to the management of children with retinoblastoma …

Retinoblastoma in the 20th century: past success and future challenges the Weisenfeld lecture

DH Abramson - Investigative ophthalmology & visual science, 2005 - iovs.arvojournals.org
Retinoblastoma is the most common primary cancer of the eye in children. 1 Although it
represents only approximately 4% of childhood cancer and less than 1% of all human …

Outcome following initial external beam radiotherapy in patients withreese-ellsworth group vb retinoblastoma

DH Abramson, KL Beaverson, ST Chang… - Archives of …, 2004 - jamanetwork.com
Objective To describe patient and ocular outcomes following initial treatmentwith external
beam radiotherapy (EBT) in eyes with Reese-Ellsworth group Vbretinoblastoma. Methods …

Intraocular and extraocular retinoblastoma

EF Grabowski, DH Abramson - Hematology/Oncology …, 1987 - hemonc.theclinics.com
Retinoblastoma, the most common primary ocular malignancy of childhood, is a tumor in
which the pediatrician and pediatric oncologist can now play a much more significant role in …

Visual outcomes in children with bilateral retinoblastoma

LS Hall, E Ceisler, DH Abramson - Journal of American Association for …, 1999 - Elsevier
Background: Retinoblastoma is the most common primary intraocular tumor of childhood.
Although studies have explored trends in retinoblastoma management and prognosis, few …

Outcome of patients with a history of bilateral retinoblastoma treated for a second malignancy: The Memorial Sloan‐Kettering Experience

IJ Dunkel, WL Gerald, NS Rosenfield… - … : The Official Journal …, 1998 - Wiley Online Library
Background Patients with bilateral retinoblastoma are well recognized to have a high risk of
developing a second malignancy, but there are little published data regarding the outcome …

Current management strategies for intraocular retinoblastoma

JW Kim, DH Abramson, IJ Dunkel - Drugs, 2007 - Springer
Survival rates for retinoblastoma patients have increased dramatically over the last century,
with documented 5-year survival figures reaching 87–99% in developed countries. During …

Familial retinoblastoma: where and when?

DH Abramson, ME Mendelsohn… - Acta Ophthalmologica …, 1998 - europepmc.org
Familial retinoblastoma: where and when? - Abstract - Europe PMC Sign in | Create an
account https://orcid.org Europe PMC Menu About Tools Developers Help Contact us …

A phase II trial of carboplatin for intraocular retinoblastoma

IJ Dunkel, TC Lee, W Shi, KL Beaverson… - Pediatric blood & …, 2007 - Wiley Online Library
Background Retinoblastoma patients with RB1 germline mutations are at risk of developing
second malignancies and external beam radiation therapy increases the risk. Carboplatin …